Steroid Withdrawal Immunosuppression After Renal Transplantation
Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The investigators analyze the clinical outcome of steroid withdrawal protocol starting at 3
months after kidney transplantation using tacrolimus, Mycophenolate Mofetil (MMF), and
basiliximab. This study is an open-label, prospective, controlled clinical trial in a single
center. Those patients who fulfill the entry criteria could enter in this prospective
controlled trial of steroid withdrawal three months after transplantation.